A U.S. cannabis company has expressed interest in acquiring Aurora Cannabis Inc., prompting the Edmonton-based firm to create a special committee to review the unsolicited bid. Curaleaf Holdings Inc. disclosed its intention to purchase all shares of Aurora, aiming to form a combined cannabis entity with a presence in 17 countries worldwide. Despite attempts to negotiate privately, Curaleaf decided to publicly announce its proposal after encountering resistance from Aurora’s board. The proposed deal includes offering Aurora shareholders $4 US per share, along with an additional $0.75 US cash for each share. Aurora acknowledged receiving the acquisition proposals from Curaleaf but disputed the claim that it had declined to engage. The Canadian company emphasized its commitment to evaluating the offer in the best interest of stakeholders. While the potential merger has sparked optimism, analysts believe that the current bid undervalues Aurora’s long-term prospects. Both companies anticipate significant synergies and opportunities for growth if the acquisition proceeds, leveraging their combined revenue and operational capabilities. Curaleaf’s CEO emphasized the benefits of merging the companies, highlighting the potential for enhanced global reach and increased exposure to favorable U.S. regulatory trends.
“Curaleaf Makes Bid for Aurora Cannabis in Global Expansion”
Published:
